Meeder Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23M Sell
65,302
-895
-1% -$319K 1.32% 14
2025
Q4
$21.7M Sell
66,197
-2,313
-3% -$734K 1.17% 20
2025
Q3
$19.3M Buy
68,510
+27,584
+67% +$8M 1.1% 23
2025
Q2
$11.4M Buy
40,926
+4,771
+13% +$1.35M 0.7% 34
2025
Q1
$11.3M Buy
36,155
+36,015
+25,725% +$10.6M 0.76% 27
2024
Q4
$36.5K Sell
140
-53,303
-100% -$15.8M ﹤0.01% 418
2024
Q3
$17.2M Buy
53,443
+6,835
+15% +$2.24M 1.15% 20
2024
Q2
$14.6M Buy
46,608
+42,225
+963% +$12.4M 1.02% 22
2024
Q1
$1.25M Sell
4,383
-60,228
-93% -$17.6M 0.08% 152
2023
Q4
$18.6M Buy
64,611
+62,589
+3,095% +$17.1M 1.45% 15
2023
Q3
$543K Sell
2,022
-46,768
-96% -$11.7M 0.04% 180
2023
Q2
$10.8M Buy
48,790
+20,876
+75% +$4.84M 0.79% 26
2023
Q1
$6.75M Buy
27,914
+4,705
+20% +$1.15M 0.54% 48
2022
Q4
$6.1M Sell
23,209
-41,947
-64% -$11.2M 0.53% 37
2022
Q3
$14.7M Buy
65,156
+6,046
+10% +$1.47M 0.85% 25
2022
Q2
$14.4M Buy
59,110
+3,598
+6% +$882K 0.83% 23
2022
Q1
$13.4M Buy
+55,512
New +$12.8M 0.65% 31
2021
Q4
Sell
-42,439
Closed -$9.03M 1171
2021
Q3
$9.03M Sell
42,439
-510
-1% -$117K 0.47% 52
2021
Q2
$10.5M Buy
42,949
+417
+1% +$103K 0.49% 44
2021
Q1
$10.6M Buy
42,532
+35,432
+499% +$8.45M 0.54% 40
2020
Q4
$1.63M Sell
7,100
-36,455
-84% -$8.4M 0.36% 52
2020
Q3
$11.1M Sell
43,555
-7,353
-14% -$1.82M 0.72% 25
2020
Q2
$12M Sell
50,908
-981
-2% -$224K 0.78% 22
2020
Q1
$10.5M Sell
51,889
-161
-0.3% -$35.2K 0.82% 21
2019
Q4
$12.5M Sell
52,050
-133
-0.3% -$29.3K 0.77% 27
2019
Q3
$10.1M Buy
52,183
+904
+2% +$174K 0.67% 30
2019
Q2
$9.45M Buy
51,279
+5,266
+11% +$943K 0.66% 37
2019
Q1
$8.74M Sell
46,013
-170
-0.4% -$32.5K 0.69% 35
2018
Q4
$8.99M Sell
46,183
-204
-0.4% -$39.8K 0.8% 23
2018
Q3
$9.62M Buy
46,387
+5,010
+12% +$987K 0.72% 30
2018
Q2
$7.64M Sell
41,377
-2,170
-5% -$384K 0.66% 31
2018
Q1
$7.42M Buy
43,547
+3,779
+10% +$694K 0.69% 26
2017
Q4
$6.91M Buy
39,768
+2,163
+6% +$383K 0.59% 30
2017
Q3
$7.01M Buy
37,605
+13,421
+55% +$2.38M 0.76% 20
2017
Q2
$4.17M Sell
24,184
-4,559
-16% -$742K 0.4% 69
2017
Q1
$4.71M Sell
28,743
-2,908
-9% -$483K 0.42% 65
2016
Q4
$4.63M Sell
31,651
-2,242
-7% -$337K 0.44% 66
2016
Q3
$5.65M Buy
33,893
+9,024
+36% +$1.53M 0.48% 37
2016
Q2
$3.79M Sell
24,869
-2,759
-10% -$429K 0.35% 50
2016
Q1
$4.14M Buy
27,628
+20,241
+274% +$3.01M 0.39% 53
2015
Q4
$1.2M Sell
7,387
-20,322
-73% -$3.19M 0.11% 169
2015
Q3
$3.83M Sell
27,709
-6,997
-20% -$1.1M 0.38% 71
2015
Q2
$5.33M Buy
34,706
+9,991
+40% +$1.6M 0.54% 33
2015
Q1
$3.95M Buy
+24,715
New +$3.89M 0.42% 54

Other funds holding AMGN

Meeder Asset Management's AMGN Position: Q1 2026 in Review

Meeder Asset Management reduced its Amgen (AMGN) stake by 1.4% in Q1 2026, selling an estimated $319K and leaving 65,302 shares worth $23M. The position accounts for 1.32% of the portfolio, ranked #14.

Meeder Asset Management first reported a position in AMGN in Q1 2015 and has held it in 44 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Meeder Asset Management held 65,302 shares of Amgen worth $23M as of Q1 2026.
  • Meeder Asset Management sold 895 Amgen shares in Q1 2026, an estimated $319K.
  • Amgen made up 1.32% of Meeder Asset Management's portfolio in Q1 2026, its #14 holding.
  • Meeder Asset Management first reported a position in Amgen in Q1 2015 and has held it in 44 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.